Related case:
ITF 2021 ITF vs Elizavetka Koklina
February 1, 2022
In January 2018 the International Tennis Federation (ITF) has reported an anti-doping rule violation against the Russian minor tennis player Elizaveta Koklina after her sample tested positive for the prohibited substances Furosemide and Torasemide.
After notification the Athlete gave a prompt admission, waived her right for a hearing, accepted a provisional suspension and the sanction proposed by the ITF.
The Athlete explained with evidence that she likely ingested her mother’s Torsid (Torasemide) and/or Lasix (Furosemide) medication by mistake in October 2017. This mix up of medication occur due to she and her mother used identical pill organisers, and the pills she was taking to treat her congestion looked very similar to Torsid and Lasix.
ITF accepts the Athlete’s explanation and that the violation was not intentional. Further the WADA-accredited laboratory in Montreal confirmed that the concentration found in her sample was consistent with her use of the medication. The ITF finds that the Athlete established that she bears No Significant Fault and considers her co-operation in this case and her degree of fault as a minor.
Therefore the ITF decides on 16 April 2018 to impose a 12 month period of inelibility on the Athlete starting on the date of the sample collection, i.e. on 23 October 2017.
